Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Freelancers often seek quick payment solutions. Explore effective ways to ensure you get paid fast for your hard work.
15,585 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Rivian’s quality metrics, limited service footprint, and steep pricing are prompting investor caution in 2026. This r...
As Oracle doubles down on AI, market dynamics and debt concerns push billionaire wealth into sharp focus. Analysts de...
Kick off your week with a concise, practical set of market notes. This Tuesday reads guide blends data, strategy, and...
A new forecast from the most powerful claude model signals a substantial Solana rally by year-end 2026, backed by ris...
Microsoft is at a crossroads as investors await the July 29 results. This article dives into why the stock could rebo...
Space investors are watching a highly anticipated IPO-style moment as SpaceX nears price levels. This guide breaks do...
AST SpaceMobile faced a sharp weekly drop after announcing a large convertible debt raise. This article explains why ...
When political rhetoric collides with market movement, investors feel the pull of headlines. This article breaks down...
Amazon enters the back half of 2026 with sustained AWS growth, a scaling silicon stack, and a resilient Prime-driven ...
UNODC warns that Southeast Asia-based crime groups are expanding globally by using tech to launder money and run scam...
In July’s session, AT&T surprised with subscriber growth that outweighed a revenue miss, lifting its stock and offeri...